Two Alzheimer's Disease Treatment Drugs Included in the First Edition of Commercial Insurance Innovative Drug List
2025-12-07 /
Read about 0 minute
Author:小编
The first edition of the commercial insurance innovative drug list for 2025 has been released, with Eli Lilly's Donanemab Injection and Eisai's Lecanemab Injection, both Alzheimer's disease treatment drugs, successfully included.